The White House is considering options to maximize the production and distribution of the COVID-19 vaccine to make it available worldwide at the lowest cost, including support for the proposed removal of intellectual property rights, but a decision does not is still taken, a spokeswoman said Tuesday.
“There are many different ways to do this. At the moment, it is a way, but we had to evaluate what is more reasonable, “said White House spokeswoman Jen Psaki.
She added that US officials are also considering whether it is more effective to increase existing vaccine production in the United States.
U.S. lawmakers and nonprofits are pressuring Joe Biden’s administration to support the temporary suspension of intellectual property rights in the production of COVID-19 vaccines to help poor countries tackle the pandemic as India and other countries occasionally fight big.